Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2026 Earnings Call Transcript May 7, 2026
Xeris Biopharma Holdings, Inc. beats earnings expectations. Reported EPS is $0.01, expectations were $-0.00274.
Operator: Good morning, and welcome to the Xeris Biopharma Q1 ’26 Earnings Conference Call. [Operator Instructions] I will now pass the call over to Allison Wey for opening remarks. Please go ahead.
Allison Wey: Thank you, Sarah. Good morning, everyone, and welcome to Xeris’ First Quarter...
